Stereotactic Tumor Implantation
Stereotactic Tumor Implantation - Related Videos
10:52
Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme
0 Views •
Cited by 42 •
2012
We describe an integrated method for the precise, stereotactic implantation of human glioblastoma multiforme cells into the brains of nude mice and subsequent serial in vivo imaging to monitor growth and response to treatment of the resultant xenografts.
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
0 Views •
Cited by 9 •
2015
Stereotactic ablative body radiation therapy (SBRT) involves the precise delivery of high-dose radiation to cancer tumor targets. A novel SBRT platform offers a first-of-its-kind gimbaled radiation accelerator mounted within a pivoting O-ring gantry capable of dynamic image-guided tumor tracking. Here, we describe dynamic tumor tracking for lung targets.
02:43
Tumor Implantation and Injection of a Tumor Vaccine in a Mouse Model
0 Views •
2025
This video demonstrates a cell-based tumor vaccination assay. A mouse, intradermally injected with B16-F10 melanoma cells for tumor formation, is vaccinated with B16-F10 cells secreting Flt3L cytokine near the developed tumor. The secreted Flt3L from the vaccine promotes the maturation and proliferation of dendritic cells that then present tumor antigens to T cells in lymph nodes, triggering a targeted anti-tumor immune response.
04:48
Intracranial Cannular Implantation in a Mouse to Deliver Therapeutic Agents to Brain Tumors
0 Views •
2025
This video presents a procedure for intracranial cannula implantation in a brain tumor mouse model, to facilitate the administration of an immunotherapeutic agent. The delivery of glypican-2-specific chimeric antigen receptor T cells in the tumor microenvironment triggers T cell activation, resulting in tumor lysis and tumor regression.
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
0 Views •
Cited by 14 •
2012
Stereotactic body radiotherapy (SBRT) involves image-guided, ablative radiation delivered to cancer targets refractory to chemotherapy or to conventional radiation treatment. The robotic-armed Cyberknife SBRT system, using sophisticated target localization, delivers hypofractionated radiation doses capable of sterilizing cancer targets. This article will consider new therapeutic roles of SBRT for gynecological cancers.
FAQs
Stereotactic coordinates establish a defined anatomical target, allowing investigators to reproduce tumor placement across experimental subjects. Guided needle positioning further standardizes where the material enters the tissue, reducing variation caused by imprecise localization. This consistency makes differences in immune responses, inflammatory signaling, or treatment effects easier to attribute to the experimental variables rather than to implantation-site differences.
Injection depth and volume influence how consistently tumor cells or tissue occupy the intended anatomical region. Controlling both variables limits placement variability and helps maintain comparable starting conditions across experiments. Greater consistency is especially important when researchers evaluate local host responses, compare treatment groups, or examine how tumor location affects interactions with immune cells or infectious agents.
These models can support analysis of immune-cell recruitment and inflammatory signaling at a defined tumor site. Because implantation creates a reproducible anatomical context, researchers can examine how host responses develop around the tumor and how those responses change during experimental treatment. The approach therefore connects tumor biology with localized immunological behavior rather than relying only on broad systemic measurements.
Researchers may choose this approach when anatomical precision is important for studying tumor-associated host responses. A controlled implantation site supports consistent comparisons of immune-cell recruitment, inflammation, and treatment response among experimental groups. In immunology and infection research, the model is particularly relevant when investigators need to examine how tumors influence immune activity or how immune-directed interventions affect tumor-associated processes.
A reproducible tumor location provides a controlled setting for examining pathogen interactions with tumors and the inflammatory responses associated with those interactions. Researchers can use the model to investigate links between cancer and infectious disease, including how infection-related processes may shape tumor biology or host responses. Its defined anatomy helps separate biological effects from variation caused by inconsistent tumor placement.
The model can be used to assess responses to immunotherapies and anti-infective strategies while monitoring their relationship to tumor biology and host immunity. Consistent implantation supports comparisons across treatment conditions, including changes in immune-cell recruitment or inflammatory signaling. These outcomes can help investigators connect therapeutic effects with mechanisms linking cancer, immune responses, and infectious disease.